Covington represents emerging and high-growth companies worldwide, with a focus on industries in which the firm has deep regulatory and business expertise, including: life sciences, media and communications, software, Internet services, financial services, clean technology and telecommunications. Our early stage clients benefit from significant partners involvement, our responsiveness and our creativity, practicality and business judgment. Our intellectual property, employee benefits and other specialized lawyers play a key role in advising our early stage companies on a wide range of issues.
Covington represents a range of emerging companies: startups, development stage companies, companies with commercialized products and services, pre-IPO and public companies, and companies seeking acquisition partners or seeking to acquire other companies or products. We often become counsel to early stage companies as they consider embarking on a significant partnering or financing transaction or begin to prepare for an IPO or acquisition. We serve as general counsel to many of our clients, addressing the full range of issues that arise during each stage of the development of the client’s business, including:
- company formation;
- protection and commercialization of intellectual property;
- seed financings and venture financings at all stages;
- employment matters, executive compensation and equity incentive plans;
- strategic collaborations and joint ventures, licensing and other commercial agreements;
- IPOs, follow-on offerings and PIPES; and
- mergers and acquisitions.
In addition to these core corporate areas, our clients benefit from the ability to draw upon our regulatory expertise in the US, UK and Europe, including the FDA, FCC and SEC and the equivalent UK and European governmental agencies, and our involvement with various trade and industry organizations domestically and internationally in the biopharmaceutical, software and clean technology industries, among others. Our litigators are experienced in advising emerging companies on issues and disputes regarding intellectual property, enforcement of noncompetition agreements, contractual disputes, and securities matters.
Our securities attorneys have advised issuers on IPOs and other public offerings on the NYSE, NASDAQ, the LSE, AIM, Euronext, and other international markets.
Representative Matters
- Acorda Therapeutics, Inc. (NASDAQ: ACOR), a biopharmaceutical company focused on therapies for multiple sclerosis, spinal cord injury and other neurological disorders.
- AirIQ, Inc. (TSX: IQ), a provider of global wireless security solutions for mobile assets.
- Baltic Oil Terminals (AIM: BTC), a Russian oil and gas infrastructure business.
- cMarket, Inc., a provider of an online auction platform for organizations engaged in fundraising for non-profit causes.
- creditex, Inc., a global leader in e-trading of credit derivatives.
|
|